
The associate professor from UC San Diego discussed promising efficacy and safety data from a phase 1/2 trial.
The associate professor from UC San Diego discussed promising efficacy and safety data from a phase 1/2 trial.
The associate professor from UC San Diego discussed the ongoing phase ½ trial of CTNS-RD
The associate professor from UC San Diego discussed the curative potential of gene therapy in cystinosis.
Published: August 16th 2024 | Updated: August 19th 2024
Published: March 18th 2024 | Updated: June 3rd 2024
Published: December 7th 2024 | Updated:
Published: December 12th 2022 | Updated:
Published: July 14th 2024 | Updated:
Published: May 18th 2023 | Updated: